Pediatric Perfusion Products Market Size & Share, by Product Type (Pediatric Centrifugal Blood Pumps, Pediatric Oxygenation Systems, Pediatric Cannulae, Arterial Filters, Hemoconcentrators, Extracorporeal Circuits); End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers and Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 2686
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Pediatric Perfusion Products Market size was valued at USD 187.25 million in 2024 and is set to exceed USD 467.97 million by 2037, expanding at over 7.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of pediatric perfusion products is evaluated at USD 198.87 million.

Perfusion is the process of oxygenated blood being delivered to an organ or tissue of the body. Many neonates, infants, and children suffer from congenital heart defects (CHDs) and go through heart surgeries that need pediatric perfusion devices. These circulatory devices are mechanical support used in open-heart surgeries to bypass the blood from the lungs and heart and regulate the flow of blood. The perfusion system is also known as extracorporeal life support (ECLS) system.


Get more information on this report: Request Free Sample PDF

Pediatric Perfusion Products Sector: Growth Drivers and Challenges

Growth Drivers

Growing Rate of Cardiac Birth Defects

The rising cases of cardiac birth defects such as congenital heart diseases are primarily driving the growth of the market around the world. Congenital means present at birth.  According to March of Dime, Nearly 1 in every 100 babies is born with a heart defect in the United States each year and about 1 in every 4 babies born (about 25 percent) has a critical CHD.

Increasing Demand for Non-Invasive Treatment

The demand for non-invasive or minimally invasive treatments to cure heart defects has increased. According to the Centers for Disease Control and Prevention (CDC), 16,800 babies in the U.S. are born each year with ventricular septal defects (VSD) which have elevated the demand of the products.

Additionally, increasing awareness around the new treatment of different heart abnormalities, effective technological advancements, and rising acceptance of pediatric perfusion products among consumers are anticipated to expedite the demand for pediatric perfusion products during the forecast period.

Challenges

High Cost

High cost accompanying pediatric cardiac heart surgeries in low-income nations might hamper the growth of the global pediatric perfusion products market during the forecast period.

Additionally, strict regulatory guidelines for pediatric perfusion devices and the lesser availability of pediatric heart surgeons and perfusionists are projected to hamper the growth of the global market.

 

Pediatric Perfusion Products Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

7.3%

Base Year Market Size (2024)

USD 187.25 million

Forecast Year Market Size (2037)

USD 467.97 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Pediatric Perfusion Products Segmentation

The pediatric perfusion products market is segmented by product type, end-user, and region. Among product segmentation, the pediatric cannulae segment is anticipated to hold the largest market share during the forecast period owing to an increasing prevalence of respiratory problems among new-borns, and consumers preferring cannulae as they are created soft and flexible that makes them suitable for neonatal use in high flow oxygen therapy.

Our in-depth analysis of the global market includes the following segments:

           Product

  • Pediatric Centrifugal Blood Pumps
  • Pediatric oxygenation systems
  • Pediatric Cannulae
  • Arterial Filters
  • Hemoconcentrators
  • Extracorporeal Circuits
  • Others

             By End-User

  • Hospitals
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Clinics
  • Others
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Pediatric Perfusion Products Industry - Regional Synopsis

North America industry is predicted to hold largest revenue share by 2037, on account of high prevalence of congenital heart diseases in the U.S., increase in diagnosis rate of congenital heart diseases, high open heart surgery rate, and well-established health care infrastructure.

According to the Centers for Disease Control and Prevention (CDC), congenital heart diseases affect approximately 1% of the total pediatric population in the U.S. every year. The widespread presence of mild congenital heart diseases has increased in the country in the past five years, whereas the prevalence of critical congenital heart diseases has been stable.

Germany, the U.K., and France held the major shares of the pediatric perfusion market in Europe for the year 2018. This can be attributed to high rate of diagnosis and treatment of congenital heart diseases, highly developed health care industry, presence of ambulatory surgery centers and availability of sophisticated instruments in hospitals.

China and Japan attained dominant shares of the market in the Asia Pacific region in 2018 owing to growing patient population, and soaring investments in research & development ventures by healthcare organisations. The market in India is estimated to expand at high growth in the next few years, owing to a large population of neonates and developing health care infrastructure. However, underdeveloped health care infrastructure and unavailability of skilled pediatric heart surgeons are some of the factors that might negatively affect the growth of the pediatric perfusion market in Latin America, the Middle East & Africa during the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Pediatric Perfusion Products Landscape

    • Medtronic 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Fluigent
    • Masimo
    • Terumo Cardiovascular Systems
    • LivaNova PLC
    • Eurosets
    • General Electric Company
    • Nonin
    • Getinge AB
    • Koninklijke Philips N.V.
    • BL Lifesciences.

     


In the News

  •  January 3, 2020 – Masimo’s RD Set Sensors got clearance from the FDA. It features the company’s signature Measure-through Motion and Low Perfusion SET pulse oximetry, to exhibit much better accuracy while observing neonatal patients.

  • Perfusion Week 2020 – American Society of Extracorporeal Technology organizes PERFUSION WEEK every year to recognize the dedication of perfusionists around the world. This year April 27 marks the first day of Perfusion Week 2020.

  • February 27, 2020 – A team of researchers from Boston Children’s Hospital and Harvard developed an artificial valve that can be expanded and is comparatively cheaper to perform. Since various congenital surgeries require placement of prosthetic heart valves and as the heart grows with the infant’s age, valves have to be replaced through repeated surgeries which is altogether an expensive process.

Author Credits:  Radhika Pawar


  • Report ID: 2686
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pediatric perfusion products is evaluated at USD 198.87 million.

Pediatric Perfusion Products Market size was valued at USD 187.25 million in 2024 and is set to exceed USD 467.97 million by 2037, expanding at over 7.3% CAGR during the forecast period i.e., between 2025-2037.

North America industry is predicted to hold largest revenue share by 2037, on account of high prevalence of congenital heart diseases in the U.S., increase in diagnosis rate of congenital heart diseases, high open heart surgery rate, and well-established health care infrastructure.

The major players in the market are Medtronic, Fluigent, Masimo, Terumo Cardiovascular Systems, LivaNova PLC, Eurosets, General Electric Company, Nonin, Getinge AB, Koninklijke Philips N.V., BL Lifesciences., and others.
Pediatric Perfusion Products Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample